Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Metformin for Fibromyalgia Symptoms (INFORM Trial) [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating metformin for fibromyalgia symptoms and is currently recruiting, sponsored by the University of Utah.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: University of Utah | Conditions: Fibromyalgia Syndrome | Phase 2 | Status: RECRUITING